HLA-G and melanoma: According to the study of Agaugué et al, they developed an HLA-G+ xenotumor model by injecting melanoma tumor cells (M8) or M8 transfected with HLA-G into immunocompetent mice, and found that M8 expressing HLA-G grew rapidly, whereas M8 were rejected immediately in vivo (86).